Manulife (Manufacturers Life Insurance)’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,924
| Closed | -$271K | – | 2910 |
|
|
2024
Q4 | $271K | Buy |
22,924
+193
| +0.8% | +$2.28K | ﹤0.01% | 2497 |
|
|
2024
Q3 | $469K | Buy |
22,731
+1,600
| +8% | +$33K | ﹤0.01% | 2319 |
|
|
2024
Q2 | $956K | Buy |
21,131
+10,604
| +101% | +$480K | ﹤0.01% | 1884 |
|
|
2024
Q1 | $413K | Buy |
+10,527
| New | +$413K | ﹤0.01% | 2273 |
|
|
2021
Q2 | – | Sell |
-1,676
| Closed | -$99K | – | 3231 |
|
|
2021
Q1 | $99K | Buy |
1,676
+396
| +31% | +$23.4K | ﹤0.01% | 3046 |
|
|
2020
Q4 | $48K | Buy |
1,280
+282
| +28% | +$10.6K | ﹤0.01% | 2975 |
|
|
2020
Q3 | $54K | Sell |
998
-297
| -23% | -$16.1K | ﹤0.01% | 2887 |
|
|
2020
Q2 | $307K | Sell |
1,295
-48
| -4% | -$11.4K | ﹤0.01% | 2235 |
|
|
2020
Q1 | $211K | Buy |
1,343
+152
| +13% | +$23.9K | ﹤0.01% | 2294 |
|
|
2019
Q4 | $195K | Sell |
1,191
-55
| -4% | -$9.01K | ﹤0.01% | 2613 |
|
|
2019
Q3 | $187K | Hold |
1,246
| – | – | ﹤0.01% | 2628 |
|
|
2019
Q2 | $259K | Buy |
1,246
+57
| +5% | +$11.8K | ﹤0.01% | 2461 |
|
|
2019
Q1 | $248K | Buy |
1,189
+90
| +8% | +$18.8K | ﹤0.01% | 2317 |
|
|
2018
Q4 | $192K | Sell |
1,099
-60
| -5% | -$10.5K | ﹤0.01% | 2338 |
|
|
2018
Q3 | $262K | Sell |
1,159
-226
| -16% | -$51.1K | ﹤0.01% | 2600 |
|
|
2018
Q2 | $210K | Buy |
1,385
+83
| +6% | +$12.6K | ﹤0.01% | 3095 |
|
|
2018
Q1 | $239K | Buy |
1,302
+32
| +3% | +$5.87K | ﹤0.01% | 2883 |
|
|
2017
Q4 | $270K | Buy |
1,270
+100
| +9% | +$21.3K | ﹤0.01% | 2786 |
|
|
2017
Q3 | $251K | Sell |
1,170
-36
| -3% | -$7.72K | ﹤0.01% | 2786 |
|
|
2017
Q2 | $228K | Buy |
+1,206
| New | +$228K | ﹤0.01% | 2900 |
|
|
2016
Q4 | – | Sell |
-83
| Closed | -$17K | – | 4354 |
|
|
2016
Q3 | $17K | Buy |
+83
| New | +$17K | ﹤0.01% | 3585 |
|